Mitochondrial-Derived Peptide for Metabolic Homeostasis & Longevity
MOTS-c — Mitochondrial Open Reading Frame of the 12S rRNA-c
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome — one of the only peptides known to be encoded by mitochondrial DNA. It regulates metabolic homeostasis, insulin sensitivity, and exercise capacity by activating AMPK signaling. Circulating MOTS-c levels decline with age, and higher levels have been found in centenarians.
MOTS-c is a 16-amino-acid peptide (MRWQEMGYIFYPRKLR) encoded within the 12S rRNA gene of the mitochondrial genome. Unlike nuclear-encoded peptides, MOTS-c is translated in the mitochondrial matrix and can translocate to the nucleus under metabolic stress, directly regulating gene expression.
MOTS-c activates AMP-activated protein kinase (AMPK) in skeletal muscle and liver, mimicking the metabolic effects of exercise and caloric restriction. It also regulates the folate cycle and one-carbon metabolism, affecting nucleotide synthesis, methylation reactions, and redox balance. Under metabolic stress, MOTS-c translocates to the nucleus where it regulates stress-response genes.
MOTS-c is a peptide encoded in mitochondrial DNA that acts as a metabolic master regulator, activating AMPK to improve insulin sensitivity, increase fat burning, and promote longevity pathways. It was discovered in 2015 and found at higher levels in centenarians.
MOTS-c activates AMPK in muscle and liver, producing effects similar to intense exercise: increased glucose uptake, enhanced fat oxidation, and improved insulin sensitivity.
MOTS-c levels decline with age and obesity. Its discovery in centenarians at higher levels than in younger adults suggests it may be a key mediator of exceptional longevity.
MOTS-c is a mitochondrial-derived peptide that activates AMPK to mimic the metabolic effects of exercise, with declining levels linked to aging and metabolic disease.
Activates AMP-activated protein kinase (AMPK) in skeletal muscle and liver, mimicking the metabolic effects of exercise and caloric restriction.
Regulates the folate cycle and one-carbon metabolism, affecting nucleotide synthesis, methylation reactions, and redox balance.
Improves insulin sensitivity in skeletal muscle by activating AMPK-dependent glucose transporter (GLUT4) translocation, independent of insulin signaling.
1 cited study — model, sample size, outcome, and effect size from published literature.
| Study | Model | Sample | Outcome | Effect Size | Level |
|---|---|---|---|---|---|
Lee C, et al. (2015) The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and redu… PubMed | Rodent (mouse) — diet-induced obesity | n=40 | Reduced body weight, improved insulin sensitivity, and AMPK activation | Body weight reduction: ~15% vs. control; insulin sensitivity: ~2× improvement | Animal |
Longevity Research
≥99% purity · Third-party tested
Use code Health for 15% off
Fast FedEx shipping · 60-day guarantee
| Peptide Class | Mitochondrial-derived peptide (16 amino acids) |
| Molecular Weight | 2,174.5 Da |
| Regulatory Status | Research chemical; no clinical approval |
| Available Sizes | 5mg, 10mg vials |
| Form | Lyophilized powder |
| Purity | ≥99% (third-party tested) |
View full legal status guide →
Purgo Labs offers MOTS-c with ≥99% purity, third-party certificates of analysis, and fast FedEx shipping. This is an affiliate link — we may earn a commission at no cost to you.
Purchase MOTS-c at Purgo LabsMedical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.
